Close Menu

NEW YORK (GenomeWeb) – Centogene, a German firm focusing on genetic diagnosis of rare disease, has raised €25 million ($28 million) in a Series A financing round led by TVM Capital Life Science in collaboration with DPE Deutsche Private Equity, Careventures, and CIC Capital.

Centogene said it will use the proceeds from the financing to accelerate its growth and expansion plans in the areas of genetic testing, pharmaceutical collaborations, and big-data solutions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
03

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.